25 May 2013
Keywords: oral-lyn, trial, track, successful, early, finish, usa-based
Article | 16 March 2009
USA-based Generex Biotechnology says that, if positive data from an ongoing Phase III trial of lead product Oral-lyn, an oral ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
16 March 2009
24 May 2013
© 2013 thepharmaletter.com